United States · Series F startup

Who invested in Adimab

8 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechBig Data & Analytics

Funding summaryUpdated 26 Oct 2026

$40Mraised across 8 rounds since 2007, from 8 sources

$400KSeries A$2KVenture$5.9MSeries A$3.2MSeries B$4.0MSeries C$8.2MSeries D$4.0MVenture$14MSeries F
Latest round
Series F, $14MApr 2012
Step-upi
3.5×
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20082009201020112012
$400KSeries A$2KVenture$3.2MSeries B$4.0MSeries C$8.2MSeries D$4.0MVenture$14MSeries F
First round
Series A, $400K
Jul 2007
Biggest round
$14M
Series F · Apr 2012
Usual gap between rounds
10 months
the median of 6

The rounds

  1. Apr 2012
    Series F$14M3 returning

    Reported by adimab.comSEC filing: $14M sold, first sale Mar 2012

  2. Dec 2010
    Venture$4.0M

    No investor was named in the report.

    Reported by masshightech.comSEC filing: $4.0M sold, first sale Nov 2010

  3. Jan 2010
    Series D$8.2M1 new4 returning

    Reported by onbiovc.comSEC filing: $8.2M sold, first sale Sept 2009

  4. Nov 2008
  5. Apr 2008
    Series B$3.2M

    No investor was named in the report.

    Reported by sec.gov

  6. Sept 2007
    Series A$5.9M2 returning

    Reported by sec.gov

  7. Jul 2007
    Venture$2K

    No investor was named in the report.

    Reported by sec.gov

  8. Jul 2007
    Series A$400K2 new

    Reported by sec.gov

Founders and team

From Adimab's own website and the SEC filings it signed: 8 on the team.

  • Philip ChaseChief Executive Officer
  • Katy SenecaVice President, Finance & Accounting
  • Guy Van MeterChief Business Officer
  • Ryan McGovernChief Financial Officer
  • Kirt JohnsonSenior Director, Product Engineering & Operations
  • Errik B. AndersonExecutive Officer, Directori
  • Robert L. BirnbaumExecutive Officeri
  • Tillman U. GerngrossExecutive Officer, Directori

On the board, as filediFran J. HellerMichael J. RossTerrance L. McGuireWilliam J. Maris

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2007Venture2007Series A2007Series B2008Series C2008Series D2010Venture2010Series F2012Polaris PartnersSV Life SciencesGoogle VenturesOrbiMedBorealis Ventures

Everyone who backed them

Polaris PartnersVC firm5rounds
SV Life SciencesVC firm5rounds
Google VenturesCorporate VC2rounds
OrbiMedPrivate equity2rounds
Borealis VenturesVC firm2rounds

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Adimab as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

LaunchCapitalVC firmPer its own site

Quick answers about Adimab

Who invested in Adimab?

Adimab's investors include Polaris Partners, SV Life Sciences, Google Ventures, OrbiMed and Borealis Ventures.

How much has Adimab raised?

Adimab has raised $40M across 8 rounds since 2007.

When did Adimab last raise?

Adimab's most recent round was a Series F of $14M in Apr 2012.

What was Adimab's biggest round?

Its most recent round, $14M in Apr 2012, is also its largest on record.

Who backed Adimab first?

Adimab's first round on record, in Jul 2007, was backed by Polaris Partners and SV Life Sciences.

What stage is Adimab at?

Adimab's latest named round is a Series F, in Apr 2012.

Where is Adimab based?

Adimab is based in the United States.

Companies like Adimab

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.